title: What Should We Tell Patients About Physical Activity After a Prostate Cancer Diagnosis?
abstract: A number of observational studies and clinical trials have shown that physical activity after a diagnosis of prostate cancer is associated with a decrease in disease progression and an increase in survival, and that specific exercises reduce morbidity from prostate cancer treatments. However, providers need more guidance on what types of physical activity to recommend to patients across different disease states and treatments in prostate cancer, and when and how to initiate the discussion. In addition to evaluating important studies showing benefits of physical activity in patients with prostate cancer, this review suggests some evidence-based methods for incorporating physical activity interventions into clinical practice.
authors.forename: Sundhar
authors.initials: S
authors.lastname: Ramalingam
authors.forename: Kathryn I
authors.initials: KI
authors.lastname: Pollak
authors.forename: Leah L
authors.initials: LL
authors.lastname: Zullig
authors.forename: Michael R
authors.initials: MR
authors.lastname: Harrison
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D018450:Disease Progression; D064420:Drug-Related Side Effects and Adverse Reactions / Q000517:prevention & control; D019317:Evidence-Based Medicine; D006801:Humans; D008297:Male; D009043:Motor Activity; D011183:Postoperative Complications / Q000517:prevention & control; D011468:Prostatectomy / Q000009:adverse effects / Q000401:mortality; D011471:Prostatic Neoplasms / Q000175:diagnosis* / Q000401:mortality / Q000628:therapy*; D011832:Radiation Injuries / Q000517:prevention & control; D011878:Radiotherapy / Q000009:adverse effects; D012307:Risk Factors; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D000970:Antineoplastic Agents